242 related articles for article (PubMed ID: 9569050)
1. Mutations in residues of TP53 that directly contact DNA predict poor outcome in human primary breast cancer.
Berns EM; van Staveren IL; Look MP; Smid M; Klijn JG; Foekens JA
Br J Cancer; 1998 Apr; 77(7):1130-6. PubMed ID: 9569050
[TBL] [Abstract][Full Text] [Related]
2. Complete sequencing of TP53 predicts poor response to systemic therapy of advanced breast cancer.
Berns EM; Foekens JA; Vossen R; Look MP; Devilee P; Henzen-Logmans SC; van Staveren IL; van Putten WL; Inganäs M; Meijer-van Gelder ME; Cornelisse C; Claassen CJ; Portengen H; Bakker B; Klijn JG
Cancer Res; 2000 Apr; 60(8):2155-62. PubMed ID: 10786679
[TBL] [Abstract][Full Text] [Related]
3. TP53 and MYC gene alterations independently predict poor prognosis in breast cancer patients.
Berns EM; Klijn JG; Smid M; van Staveren IL; Look MP; van Putten WL; Foekens JA
Genes Chromosomes Cancer; 1996 Jul; 16(3):170-9. PubMed ID: 8814449
[TBL] [Abstract][Full Text] [Related]
4. TP53 mutation is an independent prognostic marker for poor outcome in both node-negative and node-positive breast cancer.
Overgaard J; Yilmaz M; Guldberg P; Hansen LL; Alsner J
Acta Oncol; 2000; 39(3):327-33. PubMed ID: 10987229
[TBL] [Abstract][Full Text] [Related]
5. High prevalence of codon 213Arg-->Stop mutations of the TP53 gene in human ovarian cancer in the southwestern part of The Netherlands.
Schuyer M; Henzen-Logmans SC; van der Burg ME; Fieret EJ; Klijn JG; Foekens JA; Berns EM
Int J Cancer; 1998 May; 76(3):299-303. PubMed ID: 9579562
[TBL] [Abstract][Full Text] [Related]
6. Influence of mutation type on prognostic and predictive values of TP53 status in primary breast cancer patients.
Dobes P; Podhorec J; Coufal O; Jureckova A; Petrakova K; Vojtesek B; Hrstka R
Oncol Rep; 2014 Oct; 32(4):1695-702. PubMed ID: 25051299
[TBL] [Abstract][Full Text] [Related]
7. Influence of TP53 gene alterations and c-erbB-2 expression on the response to treatment with doxorubicin in locally advanced breast cancer.
Geisler S; Lønning PE; Aas T; Johnsen H; Fluge O; Haugen DF; Lillehaug JR; Akslen LA; Børresen-Dale AL
Cancer Res; 2001 Mar; 61(6):2505-12. PubMed ID: 11289122
[TBL] [Abstract][Full Text] [Related]
8. Heterogeneity in the clinical phenotype of TP53 mutations in breast cancer patients.
Alsner J; Yilmaz M; Guldberg P; Hansen LL; Overgaard J
Clin Cancer Res; 2000 Oct; 6(10):3923-31. PubMed ID: 11051239
[TBL] [Abstract][Full Text] [Related]
9. Worse survival for TP53 (p53)-mutated breast cancer patients receiving adjuvant CMF.
Andersson J; Larsson L; Klaar S; Holmberg L; Nilsson J; Inganäs M; Carlsson G; Ohd J; Rudenstam CM; Gustavsson B; Bergh J
Ann Oncol; 2005 May; 16(5):743-8. PubMed ID: 15802278
[TBL] [Abstract][Full Text] [Related]
10. The p53 gene in breast cancer: prognostic value of complementary DNA sequencing versus immunohistochemistry.
Sjögren S; Inganäs M; Norberg T; Lindgren A; Nordgren H; Holmberg L; Bergh J
J Natl Cancer Inst; 1996 Feb; 88(3-4):173-82. PubMed ID: 8632491
[TBL] [Abstract][Full Text] [Related]
11. TP53 mutational pattern in Spanish and Polish non-small cell lung cancer patients: null mutations are associated with poor prognosis.
de Anta JM; Jassem E; Rosell R; Martínez-Roca M; Jassem J; Martínez-López E; Monzó M; Sánchez-Hernández JJ; Moreno I; Sánchez-Céspedes M
Oncogene; 1997 Dec; 15(24):2951-8. PubMed ID: 9416838
[TBL] [Abstract][Full Text] [Related]
12. Genetic alterations of the TP53 gene, p53 protein expression and HPV infection in primary cervical carcinomas.
Helland A; Holm R; Kristensen G; Kaern J; Karlsen F; Trope C; Nesland JM; Børresen AL
J Pathol; 1993 Oct; 171(2):105-14. PubMed ID: 8283348
[TBL] [Abstract][Full Text] [Related]
13. A comparison between p53 accumulation determined by immunohistochemistry and TP53 mutations as prognostic variables in tumours from breast cancer patients.
Alsner J; Jensen V; Kyndi M; Offersen BV; Vu P; Børresen-Dale AL; Overgaard J
Acta Oncol; 2008; 47(4):600-7. PubMed ID: 18465328
[TBL] [Abstract][Full Text] [Related]
14. TP53 mutation status and gene expression profiles are powerful prognostic markers of breast cancer.
Langerød A; Zhao H; Borgan Ø; Nesland JM; Bukholm IR; Ikdahl T; Kåresen R; Børresen-Dale AL; Jeffrey SS
Breast Cancer Res; 2007; 9(3):R30. PubMed ID: 17504517
[TBL] [Abstract][Full Text] [Related]
15. [Analysis of prognostic value of TP53 gene mutations in non-small cell lung cancer].
Szymanowska A; Jassem E; Dziadziuszko R; Skrzypski M; Kobierska-Gulida G; Holm K; Borg A; Rzyman W; Limon J; Jassem J
Pneumonol Alergol Pol; 2005; 73(3):264-9. PubMed ID: 16989164
[TBL] [Abstract][Full Text] [Related]
16. TP53 mutations and abnormal p53 protein staining in breast carcinomas related to prognosis.
Thorlacius S; Thorgilsson B; Björnsson J; Tryggvadottir L; Börresen AL; Ogmundsdottir HM; Eyfjörd JE
Eur J Cancer; 1995 Oct; 31A(11):1856-61. PubMed ID: 8541113
[TBL] [Abstract][Full Text] [Related]
17. Only missense mutations affecting the DNA binding domain of p53 influence outcomes in patients with breast carcinoma.
Végran F; Rebucci M; Chevrier S; Cadouot M; Boidot R; Lizard-Nacol S
PLoS One; 2013; 8(1):e55103. PubMed ID: 23359294
[TBL] [Abstract][Full Text] [Related]
18. The expression of vascular endothelial growth factor correlates with mutant p53 and poor prognosis in human breast cancer.
Linderholm BK; Lindahl T; Holmberg L; Klaar S; Lennerstrand J; Henriksson R; Bergh J
Cancer Res; 2001 Mar; 61(5):2256-60. PubMed ID: 11280795
[TBL] [Abstract][Full Text] [Related]
19. Predictive value of tumour cell proliferation in locally advanced breast cancer treated with neoadjuvant chemotherapy.
Aas T; Geisler S; Eide GE; Haugen DF; Varhaug JE; Bassøe AM; Thorsen T; Berntsen H; Børresen-Dale AL; Akslen LA; Lønning PE
Eur J Cancer; 2003 Mar; 39(4):438-46. PubMed ID: 12751373
[TBL] [Abstract][Full Text] [Related]
20. Oropharyngeal squamous cell carcinoma treated with radiotherapy or radiochemotherapy: prognostic role of TP53 and HPV status.
Fallai C; Perrone F; Licitra L; Pilotti S; Locati L; Bossi P; Orlandi E; Palazzi M; Olmi P
Int J Radiat Oncol Biol Phys; 2009 Nov; 75(4):1053-9. PubMed ID: 19577857
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
